Suppr超能文献

比较不同体内孵育部位构建组织工程化小肠。

Comparison of Different In Vivo Incubation Sites to Produce Tissue-Engineered Small Intestine.

机构信息

1 Department of Pediatric Surgery, The Research Institute at Nationwide Children's Hospital , Columbus, Ohio.

2 Nanofiber Solutions, Inc. , Hilliard, Ohio.

出版信息

Tissue Eng Part A. 2018 Jul;24(13-14):1138-1147. doi: 10.1089/ten.TEA.2017.0313. Epub 2018 Mar 1.

Abstract

OBJECTIVE

The objective of this study was to compare the impact of different in vivo incubation sites on the production of tissue-engineered small intestine (TESI).

MATERIALS AND METHODS

Green fluorescent protein transgenic rat pups (3-5 days) were used as donors of intestinal organoids. Harvested intestine was exposed to enzymatic digestion to release intestinal stem cell-containing organoids. Organoids were purified, concentrated, and seeded onto tubular polyglycolic acid scaffolds. Seeded scaffolds were implanted in each of five locations in recipient female nude rats: wrapped with omentum, wrapped with intestinal mesentery, wrapped with uterine horn membrane, attached to the abdominal wall, and inserted into the subcutaneous space. After 4 weeks of in vivo incubation, specimens from each site were explanted for evaluation.

RESULTS

Wrapping seeded scaffolds with vascularized membranes produced TESI with variable lengths of vascularized pedicles, with the longest pedicle length from uterine horn membrane, the shortest pedicle length from intestinal mesentery, and intermediate length from omentum. The quantity of TESI, as expressed by volume and neomucosal length, was identical in TESI produced by wrapping with any of the three membranes. The smallest quantity of TESI was found in TESI produced from insertion into the subcutaneous space, with an intermediate quantity of TESI produced from attachment to the abdominal wall. Periodic acid-Schiff and immunofluorescence (IF) staining confirmed the presence of all intestinal epithelial cell lineages in TESI produced at all incubation sites. Additional IF staining demonstrated the presence of enteric nervous system components and blood vessels. Wrapping of seeded scaffolds with vascularized membranes significantly increased the density of blood vessels in the TESI produced.

CONCLUSION

Wrapping of seeded scaffolds in vascularized membranes produced the largest quantity and highest quality of TESI. Attaching seeded scaffolds to the abdominal wall produced an intermediate quantity of TESI, but the quality was still comparable to TESI produced in vascularized membranes. Insertion of seeded scaffolds into the subcutaneous space produced the smallest quantity and lowest quality of TESI. In summary, wrapping seeded scaffolds with vascularized membranes is favorable for the production of TESI, and wrapping with omentum may produce TESI that is most easily anastomosed with host intestine.

摘要

目的

本研究旨在比较不同体内孵育部位对组织工程化小肠(TESI)生成的影响。

材料与方法

采用绿色荧光蛋白转基因大鼠幼仔(3-5 日龄)作为肠类器官供体。采集的肠段经酶消化释放含有肠干细胞的类器官。类器官经纯化、浓缩后种植到聚乙二醇酸管型支架上。将种植后的支架分别植入受体雌性裸鼠的五个部位:用大网膜包裹、用肠系膜包裹、用子宫角膜包裹、贴附于腹壁、植入皮下间隙。体内孵育 4 周后,从每个部位取出标本进行评估。

结果

用血管化膜包裹种植的支架可生成具有不同长度血管蒂的 TESI,其中以子宫角膜包裹生成的蒂最长,肠系膜包裹生成的蒂最短,大网膜包裹生成的蒂居中。用三种膜包裹生成的 TESI 的体积和新生黏膜长度表达的 TESI 数量相同。从皮下间隙植入生成的 TESI 数量最小,贴附于腹壁生成的 TESI 数量居中。过碘酸希夫(Periodic acid-Schiff,PAS)和免疫荧光(immunofluorescence,IF)染色证实了所有肠上皮细胞谱系均存在于所有孵育部位生成的 TESI 中。进一步的 IF 染色显示了肠神经系统成分和血管的存在。用血管化膜包裹种植的支架可显著增加生成的 TESI 中的血管密度。

结论

用血管化膜包裹种植的支架可生成数量最多、质量最高的 TESI。将种植的支架贴附于腹壁可生成数量居中的 TESI,但质量仍与血管化膜生成的 TESI 相当。将种植的支架植入皮下间隙可生成数量最少、质量最差的 TESI。综上所述,用血管化膜包裹种植的支架有利于 TESI 的生成,用大网膜包裹可能生成最容易与宿主肠吻合的 TESI。

相似文献

1
Comparison of Different In Vivo Incubation Sites to Produce Tissue-Engineered Small Intestine.
Tissue Eng Part A. 2018 Jul;24(13-14):1138-1147. doi: 10.1089/ten.TEA.2017.0313. Epub 2018 Mar 1.
2
Human tissue-engineered small intestine forms from postnatal progenitor cells.
J Pediatr Surg. 2013 Jan;48(1):129-37. doi: 10.1016/j.jpedsurg.2012.10.029.
3
Tissue engineering the small intestine.
Clin Gastroenterol Hepatol. 2013 Apr;11(4):354-8. doi: 10.1016/j.cgh.2013.01.028. Epub 2013 Feb 4.
4
Production of Tissue-Engineered Small Intestine in Rats with Different Ages of Cell Donors.
Tissue Eng Part A. 2019 Jun;25(11-12):878-886. doi: 10.1089/ten.TEA.2018.0226. Epub 2018 Nov 7.
5
Enriched Intestinal Stem Cell Seeding Improves the Architecture of Tissue-Engineered Intestine.
Tissue Eng Part C Methods. 2015 Aug;21(8):816-24. doi: 10.1089/ten.TEC.2014.0389. Epub 2015 Mar 12.
7
8
Production of tissue-engineered intestine from expanded enteroids.
J Surg Res. 2016 Jul;204(1):164-75. doi: 10.1016/j.jss.2016.02.030. Epub 2016 Mar 3.
9
Human and mouse tissue-engineered small intestine both demonstrate digestive and absorptive function.
Am J Physiol Gastrointest Liver Physiol. 2015 Apr 15;308(8):G664-77. doi: 10.1152/ajpgi.00111.2014. Epub 2015 Jan 8.
10
A multicellular approach forms a significant amount of tissue-engineered small intestine in the mouse.
Tissue Eng Part A. 2011 Jul;17(13-14):1841-50. doi: 10.1089/ten.TEA.2010.0564. Epub 2011 May 4.

引用本文的文献

1
Building gut from scratch - progress and update of intestinal tissue engineering.
Nat Rev Gastroenterol Hepatol. 2022 Jul;19(7):417-431. doi: 10.1038/s41575-022-00586-x. Epub 2022 Mar 3.
2
Pre-Vascularized Electrospun Graphene Oxide-Gelatin Chamber for Intestinal Wall Defect Repair.
Int J Nanomedicine. 2022 Feb 15;17:681-695. doi: 10.2147/IJN.S353029. eCollection 2022.
3
Intestinal Models for Personalized Medicine: from Conventional Models to Microfluidic Primary Intestine-on-a-chip.
Stem Cell Rev Rep. 2022 Aug;18(6):2137-2151. doi: 10.1007/s12015-021-10205-y. Epub 2021 Jun 28.
4
A Comparison of Sterilization Techniques for Production of Decellularized Intestine in Mice.
Tissue Eng Part C Methods. 2020 Feb;26(2):67-79. doi: 10.1089/ten.TEC.2019.0219. Epub 2020 Jan 14.
5
Gut bioengineering promotes gut repair and pharmaceutical research: a review.
J Tissue Eng. 2019 Apr 19;10:2041731419839846. doi: 10.1177/2041731419839846. eCollection 2019 Jan-Dec.
6
Production of Tissue-Engineered Small Intestine in Rats with Different Ages of Cell Donors.
Tissue Eng Part A. 2019 Jun;25(11-12):878-886. doi: 10.1089/ten.TEA.2018.0226. Epub 2018 Nov 7.

本文引用的文献

1
The mesentery: structure, function, and role in disease.
Lancet Gastroenterol Hepatol. 2016 Nov;1(3):238-247. doi: 10.1016/S2468-1253(16)30026-7. Epub 2016 Oct 12.
2
HB-EGF embedded in PGA/PLLA scaffolds via subcritical CO2 augments the production of tissue engineered intestine.
Biomaterials. 2016 Oct;103:150-159. doi: 10.1016/j.biomaterials.2016.06.039. Epub 2016 Jun 21.
3
Engineered VEGF-releasing PEG-MAL hydrogel for pancreatic islet vascularization.
Drug Deliv Transl Res. 2015 Apr;5(2):125-36. doi: 10.1007/s13346-013-0142-2.
4
Enriched Intestinal Stem Cell Seeding Improves the Architecture of Tissue-Engineered Intestine.
Tissue Eng Part C Methods. 2015 Aug;21(8):816-24. doi: 10.1089/ten.TEC.2014.0389. Epub 2015 Mar 12.
8
Historical development of mesenteric anatomy provides a universally applicable anatomic paradigm for complete/total mesocolic excision.
Gastroenterol Rep (Oxf). 2014 Nov;2(4):245-50. doi: 10.1093/gastro/gou046. Epub 2014 Jul 16.
9
Scaffolding for challenging environments: materials selection for tissue engineered intestine.
J Biomed Mater Res A. 2014 Nov;102(11):3795-802. doi: 10.1002/jbm.a.35047. Epub 2013 Dec 12.
10
Poor osteoinductive potential of subcutaneous bone cement-induced membranes for tissue engineered bone.
Connect Tissue Res. 2013;54(4-5):283-9. doi: 10.3109/03008207.2013.811499. Epub 2013 Aug 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验